[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337601-105":59,"doc-detail-337601-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","incidence-and-mortality-of-cancers-in-female-genital-organs-china-2022","Incidence and Mortality of Cancers in Female Genital Organs - China, 2022","","Study estimates the incidence and mortality of cancers affecting female genital organs in China, detailing trends from 2010 to 2018 and projecting 2022 burden. Data from 700 population-based cancer registries informed 2018 incidence and mortality, with 106 registries supporting continuous trend analyses using an age-period-cohort model. Age-standardized incidence and mortality rates were calculated using Segi’s world population, with Joinpoint regression to quantify changes. Results indicate 296,300 new cases and 104,900 deaths in 2022, with distinct urban-rural patterns by cancer site.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/incidence-and-mortality-of-cancers-in-female-genital-organs-china-2022/337601/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/incidence-and-mortality-of-cancers-in-female-genital-organs-china-2022/337601.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What data sources were used to estimate cancer incidence and mortality in China for 2022?","Question",{"text":112,"@type":113},"The study used 700 population-based cancer registries for high-quality surveillance data in 2018, aggregated to estimate incidence and mortality by sex, age, and geography. For trend analysis from 2010 to 2018, 106 registries with continuous monitoring data were included.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were incidence and mortality rates calculated and compared over time?",{"text":117,"@type":113},"Age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) were calculated using Segi’s world standard population. Trends were assessed using Joinpoint regression, reporting annual percent changes (APC) and average annual percent change (AAPC).",{"name":119,"@type":110,"acceptedAnswer":120},"What were the estimated overall numbers of cases and deaths in 2022?",{"text":121,"@type":113},"In 2022, the study estimated 296,300 new cases and 104,900 deaths from cancers affecting female genital organs in China.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337601,1790470939,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","China CDC Weekly  \nVital Surveillances  \nIncidence and Mortality of Cancers in Female Genital Organs  \n—China, 2022  \nKexin Sun1; Bingfeng Han1; Hongmei Zeng1; Shaoming Wang1; Li Li1; Ru Chen1;  \nRongshou Zheng1,\\#; Wenqiang Wei1,\\#  \nABSTRACT  \nIntroduction: This study presented the incidence and mortality rates of cancers affecting the female genital organs in China, along with their trends spanning from 2010 to 2018.  \nMethods: 700 population-based cancer registries provided relevant cancer incidence and mortality data for the year 2018. Among these, 106 registries had continuous monitoring data suitable for trend analysis from 2010 to 2018. We focused specifically on cancers affecting female genital organs (ICD10=C51–C54, C56) and projected their incidences and mortalities in China for 2022 based on data from 2018 and the trends observed from 2010 to 2018. Age-standardized incidence rate (ASIR) and mortality rate (ASMR) were calculated using Segi’s world standard population.  \nResults: In 2022, there were an estimated 296,300 new cases and 104,900 deaths from female cancers in China. ASIRs for vulva (C51), vagina (C52), cervix uteri (C53), corpus uteri (C54), and ovary (C56) were 0.32, 0.23, 13.83, 6.84, and 5.68 per 100,000 population. ASIRs for corpus uteri and ovary cancers were higher in urban areas. ASMRs for vulva, vagina, cervix, corpus uteri, and ovary cancers were 0.14, 0.08, 4.54, 1.05, and 2.64 per 100,000 population, respectively. ASMR for ovarian cancer was higher in urban areas. ASIRs and ASMRs for most female genital organ cancers increased from 2010 to 2018, although the rate of increase for vulvar and cervical cancers in rural areas has slowed recently.  \nConclusions: Tailored cancer prevention and control programs specific to each region are necessary to address the growing disease burden.  \nGlobally, female genital organ cancers (vulva, vagina, cervix, corpus uteri, ovary) accounted for approximately 15% of all female cancer cases and  \nfatalities ( 1 −2) . In February 2024, the International Agency for Research on Cancer (IARC) published the most recent data on cancer incidence globally across 185 countries. It was estimated that there were 1,472,801 new cases and 680,041 deaths attributed to female genital organ cancers worldwide in 2022 (3) .  \nThe World Health Organization (WHO) Global Cervical Cancer Elimination Initiative, launched in 2020, underscored the importance of ongoing surveillance and monitoring of female-specific cancers as a critical component of effective intervention strategies against these diseases. Yet, in China, there is a notable scarcity of recent surveillance data regarding cancers of the female genital tract, particularly those affecting less common sites such as the vulva and vagina. Addressing this deficiency, our study aimed to present the latest incidence and mortality figures for cancers of the female genital organs in 2022, as well as their epidemiological trends spanning from 2010 to 2018 within China. These findings were consistent with the data published in GLOBOCAN 2022. The insights garnered from this research are intended to assess the impact of existing cancer prevention and control measures for women and to guide future health policy decisions in China.  \nMETHODS  \nData Sources  \nA total of 700 population-based cancer registries in China provided high-quality cancer surveillance data in 2018, which were aggregated to estimate cancer incidence and mortality rates based on sex (male/female), age groups (0–84 in 5-year increments, and ≥85 years), and geographical regions (urban/rural) . Out of these registries, 106 provided consistent highquality data from 2010 to 2018, which were combined to analyze rate trends over this period using an ageperiod-cohort model. Detailed information on quality control and calculations can be found in a previous publication (4) . Projections for cancer incidence and  \nChinese Center for Disease Control and Prevention CCDC Weekly / Vol","cbCaitea5snD6ckv","https://ap.wps.com/l/cbCaitea5snD6ckv","pdf",635478,"English","# Abstract\n# Methods\n## Data Sources\n## Statistical Analysis\n# Results\n## Incidence in 2022\n# Conclusions","[{\"question\":\"What data sources were used to estimate cancer incidence and mortality in China for 2022?\",\"answer\":\"The study used 700 population-based cancer registries for high-quality surveillance data in 2018, aggregated to estimate incidence and mortality by sex, age, and geography. For trend analysis from 2010 to 2018, 106 registries with continuous monitoring data were included.\"},{\"question\":\"How were incidence and mortality rates calculated and compared over time?\",\"answer\":\"Age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) were calculated using Segi’s world standard population. Trends were assessed using Joinpoint regression, reporting annual percent changes (APC) and average annual percent change (AAPC).\"},{\"question\":\"What were the estimated overall numbers of cases and deaths in 2022?\",\"answer\":\"In 2022, the study estimated 296,300 new cases and 104,900 deaths from cancers affecting female genital organs in China.\"}]","Incidence and Mortality of Cancers in Female Genital Organs - China, 2022 | PDF",1790019744,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c931df9d00cdf1dbc83cb3ea33159ea5.webp",983,1334,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b210b874718166b4e14e8ae5d09a9f77.webp",982,1333,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6df9b9f8cac2f0d7053a217c3740ee5b.webp",981,1332,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de084a6dc90660850115ec9a96a33a05.webp",980,1330]